The new course focuses on understanding “the staging, diagnosis, prognosis and treatment” of the disease, the medical terminology used for both underwriting and assessing product definition requirements when claims are made, and the minimum definitions for cancer outlined in the Life Insurance Code of Practice.
Additionally, the course will give advisers references which can be used to “quantify the financial impact” the disease will have on clients, the statement said.
“Cancer represents the largest category of claims for TAL and it costs Australia more than $4.8 billion per year in direct health system costs,” said TAL general manager for health services Sally Phillips.
“We want to lead the industry in understanding medical conditions such as cancer, and one way we are doing this is by equipping our adviser partners with the knowledge and tools they need to get the best outcomes for clients that are at risk of, or faced with, cancer.”
The course will be run through the company’s Risk Academy and presented by TAL’s health services team, the statement said.
